AI Science Tracker

Medical University of South Carolina

1 discovery from 2024

Discoveries

Spatial glycan imaging and machine learning identify a serum N-glycan panel for HCC in cirrhosis

Spatial N-glycan imaging of hepatocellular carcinoma (HCC) tissue and paired serum identified thirteen altered glycan structures; glycoproteomics linked them to more than 50 proteins, and sixteen glycoproteins were assessed in a separate patient set. Machine-learning algorithms combining glycan/glycoprotein features with clinical variables differentiated early-stage HCC from cirrhosis in a case-control cohort of 100 HCC and 101 cirrhosis-only patients, with reported AUROC values across the algorithms of 0.88–0.97.

Technology: Machine-learning algorithms using serum N-glycan and glycoprotein features, age, sex and AFP

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Machine-learning algorithms combining glycan/glycoprotein features with clinical variables differentiated early-stage HCC from cirrhosis in a case-control cohort of 100 HCC and 101 cirrhosis-only patients, with reported AUROC values across the algorithms of 0.88–0.97.
  • Still unknown: The discovery samples included 53 HCC tissues and 23 matched sera; the 201-patient testing set was a case-control cohort, not prospective surveillance. The paper notes that sialic acid was removed before analysis, excluding an important class of glycan modification. It does not establish screening benefit or prospective clinical utility. Individual glycoforms were weak classifiers; performance came from combined feature algorithms.
  • AI role: Researchers used spatial glycan imaging and glycoproteomics to select altered tissue and matched-serum features, then used machine-learning algorithms to combine selected glycan/glycoprotein measurements with clinical variables for HCC-versus-cirrhosis classification. The source reports model performance in an independent case-control patient set.

Evidence sources: https://www.nature.com/articles/s43856-024-00677-7.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 86 of works of the same type, year and subfield (OpenAlex work metrics, 17 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.